Q & M Dental Group (Singapore) (QC7) H2 2025 earnings summary

Executive summary

• Achieved 16% profit growth in core dental business, rising from $26.1m in FY2024 to $30.4m in FY2025.

• Total revenue increased 9% year-over-year to $197.2m for FY2025.

• Robust cash position of $117.1m as of 31 Dec 2025, supporting strategic expansion.

• Announced a 2nd interim dividend of 0.42 cent per share and expanded share buyback allocation to 90 million shares.

Financial highlights

• Core dental revenue grew 12% year-over-year to $195.0m, offsetting a 68% decline in other business revenue.

• PATMI decreased 35% to $9.3m, but adjusted PATMI (excluding other gains/losses, MTN, PSP) rose 1% to $17.0m.

• Cash and cash equivalents surged from $34.3m to $117.1m year-over-year.

• Bank borrowings plus finance leases increased to $143.4m from $73.7m year-over-year.

Outlook and guidance

• Pursuing Asia-Pacific regional expansion with a partnership-driven acquisition model, combining cash and equity.

• Focus on talent development and operational scalability for sustainable earnings growth.

• Plans to deploy up to RMB43.7m (S$8.0m) for dental clinic acquisitions in China to broaden geographic footprint.